Leuthold Group’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-33,022
Closed -$3.28M 213
2019
Q3
$3.28M Sell
33,022
-1,666
-5% -$158K 0.43% 90
2019
Q2
$3.21M Sell
34,688
-2,133
-6% -$203K 0.41% 96
2019
Q1
$3.47M Sell
36,821
-1,149
-3% -$100K 0.47% 87
2018
Q4
$2.43M Sell
37,970
-1,990
-5% -$147K 0.35% 105
2018
Q3
$3.58M Buy
+39,960
New +$3.53M 0.39% 99
2016
Q1
Sell
-42,548
Closed -$5.1M 223
2015
Q4
$5.1M Buy
42,548
+2,119
+5% +$245K 0.53% 67
2015
Q3
$4.37M Sell
40,429
-5,358
-12% -$665K 0.46% 81
2015
Q2
$5.3M Buy
45,787
+2,224
+5% +$254K 0.5% 76
2015
Q1
$5.02M Buy
43,563
+143
+0.3% +$17.1K 0.47% 78
2014
Q4
$4.86M Buy
+43,420
New +$4.58M 0.48% 71
2013
Q4
Sell
-2,886
Closed -$222K 326
2013
Q3
$222K Sell
2,886
-41,108
-93% -$2.88M 0.02% 301
2013
Q2
$2.57M Buy
+43,994
New +$2.65M 0.24% 115

Other funds holding CELG

Leuthold Group's CELG Position: Q4 2019 in Review

Leuthold Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 33,022 shares — an estimated $3.28M sold.

Leuthold Group first reported a position in CELG in Q2 2013 and held it in 12 quarters. The position peaked at $5.3M in Q2 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Leuthold Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Leuthold Group sold 33,022 Celgene Corp shares in Q4 2019, an estimated $3.28M.
  • Leuthold Group first reported a position in Celgene Corp in Q2 2013 and held it in 12 quarters.
  • Leuthold Group's Celgene Corp position peaked at $5.3M in Q2 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Leuthold Group's 13F filing for Q4 2019, filed 14 Feb 2020.